CollPlant Biotechnologies (CLGN) EBITDA Margin Growth (3y) (2020 - 2025)
CollPlant Biotechnologies (CLGN) EBITDA Margin Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -40,178.00 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 530.00 |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 281,207.00 |
| Sep 30, 2025 | -45,546.00 |
| Jun 30, 2025 | 811,633.00 |
| Dec 31, 2024 | -119,607.00 |
| Sep 30, 2024 | -11.13 Mn |
| Jun 30, 2024 | 221,275.00 |
| Mar 31, 2024 | 434,820.00 |
| Dec 31, 2023 | -160,371.00 |
| Sep 30, 2023 | -1,771.00 |
| Jun 30, 2023 | 28,819.00 |
| Mar 31, 2023 | 109,300.00 |
| Dec 31, 2022 | -906,321.00 |
| Sep 30, 2022 | -457,198.00 |
| Jun 30, 2022 | -659,173.00 |
| Dec 31, 2021 | -126,251.00 |
| Sep 30, 2021 | -278,991.00 |
| Jun 30, 2021 | -138,778.00 |
| Mar 31, 2021 | -92,419.00 |
| Dec 31, 2020 | -71,091.00 |